APPLICATION
ANDA077425
TYPE
ANDA
ORIGINAL APPROVAL
2013-08-29
LATEST ACTION
2023-10-27
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
ADENOSINEPrescription
ADENOSINE 90MG/30ML (3MG/ML) · SOLUTION · INTRAVENOUS
ADENOSINEPrescription
ADENOSINE 60MG/20ML (3MG/ML) · SOLUTION · INTRAVENOUS
Approval history
2023-10-27Labeling · Supplement 9 · standardAP
2015-05-18Labeling · Supplement 4 · standardAP
2015-05-18Labeling · Supplement 2 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.